Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed grouped question UIN question first answered answering member label attachment file name title
tabling member	label

Search

1714010

	registered interest
	date	25/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Prescription Drugs: Shortages
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask His Majesty's Government what assessment they have made of shortages in the supply of prescription drugs.
	tabling member printed	The Lord Bishop of Southwark
	uin	HL4117
	answer	answer is ministerial correction date of answer 30/04/2024 answer text <p>There are approximately 14,000 medicines licensed for supply in the United Kingdom, and the overwhelming majority are in good supply. The medicine supply chain is complex, global, and highly regulated, and supply issues can be caused by a range of factors. For example, suppliers can encounter manufacturing problems, difficulty accessing raw materials, and surges in demand. These are commonly cited as the drivers of the recent supply issues, which have affected many countries, not just the UK.</p><p>Whilst we can’t always prevent supply issues, we have a range of well-established tools and processes to mitigate risks to patients. These include close and regular engagement with suppliers, use of alternative strengths or forms of a medicine to allow patients to remain on the same product, expediting regulatory procedures, sourcing unlicensed imports from abroad, adding products to the restricted exports and hoarding list, use of Serious Shortage Protocols, and issuing National Health Service communications to provide management advice and information on the issue to healthcare professionals, so they can advise and support their patients.</p> answering member printed Lord Markham question first answered 30/04/2024 11:37:26 answering member 4948 label Biography information for Lord Markham
	tabling member	4345 label Biography information for The Lord Bishop of Southwark

1713721

	registered interest
	date	24/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Aviation: Medical Equipment
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask His Majesty's Government what assessment they have made of operation of law in relation to the provision of adrenaline auto-injectors on commercial aircraft.
	tabling member printed	Lord Kennedy of Southwark
	uin	HL4071
	answer	answer is ministerial correction date of answer 30/04/2024 answer text <p>Following their review, the Adrenaline Auto-injector Expert Working Group (AAI EWG) recommended in principle that adrenaline auto-injectors (AAIs) should be made available in public locations, for use in treating anaphylaxis in unforeseen and critical circumstances, provided suitable safeguards can be implemented to ensure their effective and safe use. Challenges lie in ensuring correct and secure storage of AAIs, to ensure that the adrenaline does not deteriorate, and the device remains functional. Cinemas offering food for sale and other food outlets were identified as examples of locations where emergency AAIs might have particular potential to save lives.</p><p>The legislative change will therefore concern AAI supply, to specify or define individuals or organisations with the necessary competence to obtain and store AAIs for use in the event of an anaphylactic emergency. The AAI EWG advised the need for access to AAIs in a broad range of settings such as restaurants, gyms, cinemas, childcare facilities, youth groups, and music festivals. To support such wide-ranging access, the scope of legal supply will need to be linked to a requirement for training, to support safe use.</p><p>An Expert Advisory Group for Allergy was established in 2023, across the Government and clinical organisations, and chaired by the National Allergy Strategy Group and the Department, to recommend further action by the Medicines and Healthcare products Regulatory Agency (MHRA), Department of Health and Social Care, Department for Education, and the National Health Service. The Department of Health and Social Care and the MHRA are currently considering updates to the 2017 guidance, to ensure that any updated clarifications are supported by evidence, and that any open questions are answered.</p> answering member printed Lord Markham grouped question UIN HL4072 HL4073 HL4074 question first answered 30/04/2024 11:25:28 answering member 4948 label Biography information for Lord Markham
	tabling member	4153 label Biography information for Lord Kennedy of Southwark

1713722

	registered interest
	date	24/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Adrenaline: Medical Equipment
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask His Majesty's Government what assessment they have made of operation of law in relation to the provision of adrenaline auto-injectors on trains.
	tabling member printed	Lord Kennedy of Southwark
	uin	HL4072
	answer	answer is ministerial correction date of answer 30/04/2024 answer text <p>Following their review, the Adrenaline Auto-injector Expert Working Group (AAI EWG) recommended in principle that adrenaline auto-injectors (AAIs) should be made available in public locations, for use in treating anaphylaxis in unforeseen and critical circumstances, provided suitable safeguards can be implemented to ensure their effective and safe use. Challenges lie in ensuring correct and secure storage of AAIs, to ensure that the adrenaline does not deteriorate, and the device remains functional. Cinemas offering food for sale and other food outlets were identified as examples of locations where emergency AAIs might have particular potential to save lives.</p><p>The legislative change will therefore concern AAI supply, to specify or define individuals or organisations with the necessary competence to obtain and store AAIs for use in the event of an anaphylactic emergency. The AAI EWG advised the need for access to AAIs in a broad range of settings such as restaurants, gyms, cinemas, childcare facilities, youth groups, and music festivals. To support such wide-ranging access, the scope of legal supply will need to be linked to a requirement for training, to support safe use.</p><p>An Expert Advisory Group for Allergy was established in 2023, across the Government and clinical organisations, and chaired by the National Allergy Strategy Group and the Department, to recommend further action by the Medicines and Healthcare products Regulatory Agency (MHRA), Department of Health and Social Care, Department for Education, and the National Health Service. The Department of Health and Social Care and the MHRA are currently considering updates to the 2017 guidance, to ensure that any updated clarifications are supported by evidence, and that any open questions are answered.</p> answering member printed Lord Markham grouped question UIN HL4071 HL4073 HL4074 question first answered 30/04/2024 11:25:28 answering member 4948 label Biography information for Lord Markham
	tabling member	4153 label Biography information for Lord Kennedy of Southwark

1713723

	registered interest
	date	24/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Aviation: Medical Equipment
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask His Majesty's Government what requirements there are for airlines to ensure adrenaline auto-injectors are available on commercial flights.
	tabling member printed	Lord Kennedy of Southwark
	uin	HL4073
	answer	answer is ministerial correction date of answer 30/04/2024 answer text <p>Following their review, the Adrenaline Auto-injector Expert Working Group (AAI EWG) recommended in principle that adrenaline auto-injectors (AAIs) should be made available in public locations, for use in treating anaphylaxis in unforeseen and critical circumstances, provided suitable safeguards can be implemented to ensure their effective and safe use. Challenges lie in ensuring correct and secure storage of AAIs, to ensure that the adrenaline does not deteriorate, and the device remains functional. Cinemas offering food for sale and other food outlets were identified as examples of locations where emergency AAIs might have particular potential to save lives.</p><p>The legislative change will therefore concern AAI supply, to specify or define individuals or organisations with the necessary competence to obtain and store AAIs for use in the event of an anaphylactic emergency. The AAI EWG advised the need for access to AAIs in a broad range of settings such as restaurants, gyms, cinemas, childcare facilities, youth groups, and music festivals. To support such wide-ranging access, the scope of legal supply will need to be linked to a requirement for training, to support safe use.</p><p>An Expert Advisory Group for Allergy was established in 2023, across the Government and clinical organisations, and chaired by the National Allergy Strategy Group and the Department, to recommend further action by the Medicines and Healthcare products Regulatory Agency (MHRA), Department of Health and Social Care, Department for Education, and the National Health Service. The Department of Health and Social Care and the MHRA are currently considering updates to the 2017 guidance, to ensure that any updated clarifications are supported by evidence, and that any open questions are answered.</p> answering member printed Lord Markham grouped question UIN HL4071 HL4072 HL4074 question first answered 30/04/2024 11:25:28 answering member 4948 label Biography information for Lord Markham
	tabling member	4153 label Biography information for Lord Kennedy of Southwark

1713724

	registered interest
	date	24/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Airports: Medical Equipment
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask His Majesty's Government what requirements there are for airports to ensure adrenaline auto-injectors are available on their premises.
	tabling member printed	Lord Kennedy of Southwark
	uin	HL4074
	answer	answer is ministerial correction date of answer 30/04/2024 answer text <p>Following their review, the Adrenaline Auto-injector Expert Working Group (AAI EWG) recommended in principle that adrenaline auto-injectors (AAIs) should be made available in public locations, for use in treating anaphylaxis in unforeseen and critical circumstances, provided suitable safeguards can be implemented to ensure their effective and safe use. Challenges lie in ensuring correct and secure storage of AAIs, to ensure that the adrenaline does not deteriorate, and the device remains functional. Cinemas offering food for sale and other food outlets were identified as examples of locations where emergency AAIs might have particular potential to save lives.</p><p>The legislative change will therefore concern AAI supply, to specify or define individuals or organisations with the necessary competence to obtain and store AAIs for use in the event of an anaphylactic emergency. The AAI EWG advised the need for access to AAIs in a broad range of settings such as restaurants, gyms, cinemas, childcare facilities, youth groups, and music festivals. To support such wide-ranging access, the scope of legal supply will need to be linked to a requirement for training, to support safe use.</p><p>An Expert Advisory Group for Allergy was established in 2023, across the Government and clinical organisations, and chaired by the National Allergy Strategy Group and the Department, to recommend further action by the Medicines and Healthcare products Regulatory Agency (MHRA), Department of Health and Social Care, Department for Education, and the National Health Service. The Department of Health and Social Care and the MHRA are currently considering updates to the 2017 guidance, to ensure that any updated clarifications are supported by evidence, and that any open questions are answered.</p> answering member printed Lord Markham grouped question UIN HL4071 HL4072 HL4073 question first answered 30/04/2024 11:25:28 answering member 4948 label Biography information for Lord Markham
	tabling member	4153 label Biography information for Lord Kennedy of Southwark

1713725

	registered interest
	date	24/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	First Aid: Adrenaline
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask His Majesty's Government what guidance they have issued on the administering of adrenaline auto-injectors by minors in medical emergencies.
	tabling member printed	Lord Kennedy of Southwark
	uin	HL4075
	answer	answer is ministerial correction date of answer 30/04/2024 answer text <p>The Medicines and Healthcare products Regulatory Agency (MHRA) has published guidance on the use of adrenaline auto-injectors in schools, and there is provision in this guidance for the use of an adrenaline auto-injector on someone to whom it was not prescribed, in a medical emergency. However, regulation 238 of the Human Medicines Regulations 2012 provides an exemption from certain requirements related to the administration of medicines. Specifically, it allows for parenteral, rather than injected or absorbed, administration of specified medicines in emergency situations, where the purpose is to save a life. For instance, adrenaline prescribed for a specific person, or even to an unknown person, can be administered under this regulation, if it is necessary to save a life during an emergency. The use in emergencies is covered by schedule 19 and regulation 238, where age is not specified.</p><p>An Expert Advisory Group for Allergy was established in 2023, across the Government and clinical organisations, and chaired by the National Allergy Strategy Group and the Department, to recommend further action by the MHRA, Department of Health and Social Care, Department for Education, and the National Health Service. The Department of Health and Social Care and the MHRA are currently considering updates to the 2017 guidance, to ensure that any updated clarifications are supported by evidence, and that any open questions are answered.</p> answering member printed Lord Markham grouped question UIN HL4076 question first answered 30/04/2024 11:36:16 answering member 4948 label Biography information for Lord Markham
	tabling member	4153 label Biography information for Lord Kennedy of Southwark

1713726

	registered interest
	date	24/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	First Aid: Adrenaline
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask His Majesty's Government what guidance they have issued regarding the use of an adrenaline auto-injector on someone to whom it was not prescribed in a medical emergency.
	tabling member printed	Lord Kennedy of Southwark
	uin	HL4076
	answer	answer is ministerial correction date of answer 30/04/2024 answer text <p>The Medicines and Healthcare products Regulatory Agency (MHRA) has published guidance on the use of adrenaline auto-injectors in schools, and there is provision in this guidance for the use of an adrenaline auto-injector on someone to whom it was not prescribed, in a medical emergency. However, regulation 238 of the Human Medicines Regulations 2012 provides an exemption from certain requirements related to the administration of medicines. Specifically, it allows for parenteral, rather than injected or absorbed, administration of specified medicines in emergency situations, where the purpose is to save a life. For instance, adrenaline prescribed for a specific person, or even to an unknown person, can be administered under this regulation, if it is necessary to save a life during an emergency. The use in emergencies is covered by schedule 19 and regulation 238, where age is not specified.</p><p>An Expert Advisory Group for Allergy was established in 2023, across the Government and clinical organisations, and chaired by the National Allergy Strategy Group and the Department, to recommend further action by the MHRA, Department of Health and Social Care, Department for Education, and the National Health Service. The Department of Health and Social Care and the MHRA are currently considering updates to the 2017 guidance, to ensure that any updated clarifications are supported by evidence, and that any open questions are answered.</p> answering member printed Lord Markham grouped question UIN HL4075 question first answered 30/04/2024 11:36:16 answering member 4948 label Biography information for Lord Markham
	tabling member	4153 label Biography information for Lord Kennedy of Southwark

1713739

	registered interest
	date	24/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	School Milk
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask His Majesty's Government what are the reasons for administering the Nursery Milk Scheme to children only until their fifth birthday rather than until the end of the academic year in which that birthday falls.
	tabling member printed	Lord Watson of Invergowrie
	uin	HL4089
	answer	answer is ministerial correction date of answer 29/04/2024 answer text <p>The Nursery Milk Scheme allows early years childcare settings such as childminders and nurseries to reclaim the cost of providing one-third of a pint of milk to children under five years old who attend their childcare setting for at least two hours per day. Schools are also allowed to claim under this scheme in respect of pupils under the age of five years old. There are no current plans to extend the Nursery Milk Scheme to cover other school pupils.</p><p>The School Food Standards require lower-fat or lactose free milk to be available in all schools. From the age of five years old onwards, pupils eligible for benefits-based free school meals are eligible for free school milk. In addition, the school milk subsidy scheme subsidises the cost of milk and certain milk products for children in primary and secondary schools including over fives. This means that participating schools can sell the products in schools at a lower price. More information on this scheme is available on GOV.UK in an online-only format.</p> answering member printed Lord Markham question first answered 29/04/2024 16:41:17 answering member 4948 label Biography information for Lord Markham
	tabling member	1241 label Biography information for Lord Watson of Invergowrie

1713308

	registered interest
	date	23/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Breast Cancer: Alcoholic Drinks
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask His Majesty's Government what assessment they have made of the link between women’s increasing consumption of alcohol and incidences of breast cancer.
	tabling member printed	The Lord Bishop of St Albans
	uin	HL4049
	answer	answer is ministerial correction date of answer 29/04/2024 answer text <p>Public Health England’s evidence review, <em>‘The Public Health Burden of Alcohol and the Effectiveness and Cost-Effectiveness of Alcohol Control Policies’</em>, which was published in 2016 and updated in 2018, found there is strong evidence for an association between alcohol consumption and female breast cancer, and that for breast cancer, any level of drinking increases your risk so there is no ‘safe’ level of drinking. A copy of the review is attached.</p><p>The Government believes in informing and empowering citizens and has a responsibility to provide the most up to date, clear information to enable people to make informed choices about their drinking. The 2016 United Kingdom Chief Medical Officers’ low risk drinking guidelines provide the public with the most up to date scientific information and highlight the risk of a range of health problems, including breast cancer, from alcohol consumption.</p> answering member printed Lord Markham question first answered 29/04/2024 16:52:17 answering member 4948 label Biography information for Lord Markham attachment 1 file name alcohol_public_health_burden_evidence_review_update_2018 (2).pdf title alcohol_public_health_burden_evidence_review
	tabling member	4308 label Biography information for The Lord Bishop of St Albans

1713309

	registered interest
	date	23/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Breastfeeding
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask His Majesty's Government what plans they have to put in place policies that encourage breastfeeding, including supportive work environments where women are able to breastfeed or express milk.
	tabling member printed	The Lord Bishop of St Albans
	uin	HL4050
	answer	answer is ministerial correction date of answer 29/04/2024 answer text <p>The Government’s vision, set out in the policy paper, <em>The Best Start for Life: A Vision for the 1,001 Critical Days</em>, is that every parent and carer has access to high quality infant feeding services in their local area. A copy of the paper is attached.</p><p>Through the Family Hubs and Start for Life Programme, we are investing £50 million in infant feeding services, enabling participating local authorities to design and deliver a blended offer of advice and support in line with local needs. The investment is being used to increase the range of advice and specialist support available, helping to ensure all mothers and families can meet their breastfeeding goals. We are also using programme investment to increase the capacity of the National Breastfeeding Helpline so that a greater number of families are able to access this support. In March 2024, we launched a trial of extended helpline opening hours so that support and advice will be available at any time of the day or night, every day of the year.</p><p>Regulations are in place that require employers to provide a suitable area for breastfeeding mothers. This must be hygienic and private so they can express milk if they choose to and include somewhere to store their milk.</p> answering member printed Lord Markham question first answered 29/04/2024 16:47:06 answering member 4948 label Biography information for Lord Markham attachment 1 file name The_best_start_for_life_a_vision_for_the_1_001_critical_days (9).pdf title The_best_start_for_life_a_vision
	tabling member	4308 label Biography information for The Lord Bishop of St Albans